Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy

Asakawa, Hideki; Hayashi, Isao; Fukui, Takeshi; Tokunaga, Ken

doi:10.1016/s0168-8227(03)00121-9

Cited by 34 publications

(26 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies have shown that mosapride citrate significantly improved gastric emptying in healthy volunteers, and in patients with Parkinson's disease and diabetic mellitus [16,27,28]. Recently, using capsule endoscopy or percutaneous electrogastrogram (EGG), mosapride citrate has been found to improve gastric emptying [29,30].…”

Section: Discussionmentioning

confidence: 99%

The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying

et al. 2009

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying

et al. 2009

View full text Add to dashboard Cite

show abstract

“…In one study, mosapride improved gastric motility in diabetic gastropathy and also improved glycemic control with a corresponding decrease in HgA1C [126,127] .…”

Section: Gastroparesismentioning

confidence: 98%

Gastrointestinal Motility Disorders: An Update

Lacy

Weiser

2006

Dig Dis

View full text Add to dashboard Cite

Gastrointestinal motility disorders encompass a wide array of signs and symptoms that can occur anywhere throughout the luminal gastrointestinal tract. Motility disorders are often chronic in nature and dramatically affect patients’ quality of life. These prevalent disorders cause a tremendous impact both to the individual patient and to society as a whole. Significant progress has been made over the last 5 years in understanding the etiology and pathophysiology of gastrointestinal motility disorders. This clinical update will focus on seven of the most common gastrointestinal motility disorders (achalasia, non-achalasia esophageal motility disorders, dyspepsia, gastroparesis, chronic intestinal pseudo-obstruction, irritable bowel syndrome, and chronic constipation) with an emphasis on current treatment options and new therapeutic modalities.

show abstract

“…5-HT4 agonists do not compare well with the gold standard of therapy for gastroesophageal reflux with a proton pump inhibitor; a place for 5-HT4 agonists in the management of gastroesophageal reflux has therefore not been established. Finally, 5-HT4 receptor agonists might be efficient in gastroparesis [69].…”

Section: Serotonin In Gi Diseasementioning

confidence: 99%

Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives

Lesurtel

Soll

Graf

et al. 2007

Cell. Mol. Life Sci.

123

View full text Add to dashboard Cite

Beside its role as a neurotransmitter in the central nervous system, serotonin appears to be a central physiologic mediator of many gastrointestinal (GI) functions and a mediator of the brain-gut connection. By acting directly and via modulation of the enteric nervous system, serotonin has numerous effects on the GI tract. The main gut disturbances in which serotonin is involved are acute chemotherapy-induced nausea and vomiting, carcinoid syndrome and irritable bowel syndrome. Serotonin also has mitogenic properties. Platelet-derived serotonin is involved in liver regeneration after partial hepatectomy. In diseased liver, serotonin may play a crucial role in the progression of hepatic fibrosis and the pathogenesis of steatohepatitis. Better understanding of the role of the serotonin receptor subtypes and serotonin mechanisms of action in the liver and gut may open new therapeutic strategies in hepato-gastrointestinal diseases.

show abstract

Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy

Cited by 34 publications

References 24 publications

The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying

The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying

Gastrointestinal Motility Disorders: An Update

Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives

Contact Info

Product

Resources

About